uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

Clinical trial NCT05874921 · RECRUITING

Trial details

NCT number: NCT05874921
Sponsor: UroGen Pharma Ltd.
Status: RECRUITING
Study type: OBSERVATIONAL

Urothelial Carcinoma Urothelial Carcinoma Recurrent Urothelial Carcinoma Ureter Urothelial Carcinoma Ureter Recurrent Urothelial Cancer of Renal Pelvis Urothelial Carcinoma of the Renal Pelvis and Ureter Carcinoma, Transitional Cell Transitional Cell Carcinoma of Renal Pelvis

Start date: 2023-11-17
Primary completion: 2026-04-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.